LANZAROTE OFTALMOLOGICA SL
Company details
- Active NIF/CIF: B35756394
-
Telephone: Not available
-
Date of last BORME entry: 14/04/2009
-
Sector: Human Health and Social Work Activities
-
Address: C/ ISA S/N RESIDENCIAL LAS MARINAS, BUNGALOW B-2 (TEGUISE)
-
Website: Not available
-
Featured products:
More information on LANZAROTE OFTALMOLOGICA SL
-
14/04/2009 | BORME act no.: 177606 | Register: LAS PALMASCierre provisional hoja registral art 1372 Ley 43/1995 Impuesto de Sociedades -
07/01/2004 | BORME act no.: 7823 | Register: LAS PALMASConstitución
-
07/01/2004 | BORME act no.: 7823 | Register: LAS PALMASNombramientos
-
07/01/2004 | BORME act no.: 7823 | Register: LAS PALMASModificaciones estatutarias
Other information
The CIF assigned to LANZAROTE OFTALMOLOGICA SL is B35756394, and its commercial status is active. The company is engaged in economic activities classified under the CNAE 8610 - Hospital activities. Additionally, it is categorized with the SIC code 8062 - Hospitales de medicina general y cirugía.
LANZAROTE OFTALMOLOGICA SL employs approximately Between 10 and 49 employees and records an annual turnover of less than 2 million euros. The company is registered in the Commercial Registry of Las palmas, and has 1 registration charges. The most recent announcement in Borme was published on 14/04/2009, while the last deposit of ordinary annual accounts corresponds to the year -.
To find out the contact information of LANZAROTE OFTALMOLOGICA SL, such as the telephone number, postal address, or website, you can access the Company Data module.
If you wish to obtain additional information about LANZAROTE OFTALMOLOGICA SL, we invite you to consult any of the available financial reports, the Annual Accounts of the company, or review the incidents of defaults registered in the RAI delinquency file.
The financial, commercial, and legal information about LANZAROTE OFTALMOLOGICA SL comes from official data sources and is automatically updated every day.
Do you want to know more about LANZAROTE OFTALMOLOGICA SL??
Find out more about this company by consulting these reports:
